2023 Patents
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,579,149 entitled, "Hippo Pathway Bioluminescent Biosensor," on February 14, 2023 to Taha Azad, Kazem Nouri, and Xiaolong Yang. The patent relates to bioluminescent sensors useful for monitoring and/or quantifying, in vitro or in vivo, activity of the Hippo signaling pathway.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,547,325 entitled, "Method and Apparatus for Assessing Sensorimotor Performance," on January 10, 2023 to Kayne Park and Stephen Scott. The patent relates to a method and apparatus for quantifying differences in human sensorimotor performance useful for diagnosing, assessing, and/or detecting brain injury and/or a neurological disorder, or identifying exceptional performance in a subject.